Industry Information

Update January 20, 2021

2020 inventory: Top 10 keywords in pharmaceutical circle! The seventh one deserves it!

In 2020, with the gradual implementation of "4 + 7 procurement with volume" nationwide expansion, the medical reform will continue to tackle the difficulties, the route of deepening the reform of the...

Update January 20, 2021

3.2 billion market to meet changes? Pfizer "monopolizes three yuan" in the fourth batch of centralized purchasing?

Cosmic pharmaceutical company, Pfizer, the world's largest pharmaceutical company, is under the impact of volume procurement policy, and its future direction is more complicated. According to the...

Update January 18, 2021

High level set the tone of "normalization and institutionalization of centralized drug procurement"! 2021 will be the real bidding year in the past ten years!

On January 15, in one day, there are three things worth pondering: Around 5 p.m., the four batches of national mining plan, which was rumored to be introduced this week, finally came to the surface....

Update January 16, 2021

Nuocheng Jianhua and Shanghai Pharmaceutical Science Park reach strategic cooperation

Beijing, January 13, 2021 / AP / -- a biomedical high-tech company, nuocheng Jianhua (stock exchange of Hong Kong Code: 09969), has reached a strategic cooperation with Shanghai Pharmaceutical...

Update January 16, 2021

2020 inventory: peak sales forecast of new drugs approved by FDA and EMA in the United States! Gilead, vertex, Roche, Pfizer, Novartis

2020 is a "eventful year" for the pharmaceutical industry. Many pharmaceutical companies around the world are developing covid-19 therapeutic drugs or vaccines at a fanatical pace. So far, covid-19...

Update January 13, 2021

Inventory in 2020: analysis of imported ind varieties of "chemical drug category 1", Roche, Novartis, Baiji, Xinda

In 2020, China's domestic new drug ind declaration will reach a new record. Although the global epidemic has brought many difficulties, it has not delayed the enthusiasm and pace of domestic new drug...

Update January 12, 2021

Interim Measures for designated management of medical security in medical institutions and Interim Measures for designated management of medical security in retail pharmacies

1、 What is the background of the promulgation of the Interim Measures for the designated management of medical security in medical institutions and the Interim Measures for the designated management...

Update January 11, 2021

Proper storage of α - lipoic acid

[basic characters of α - lipoic acid] α - lipoic acid, light yellow powder crystal, almost tasteless. The solubility in water is about 1 g / L (20 ° C). It is soluble in 10% NaOH solution and...

Update January 05, 2021

Yasheng pharmaceutical won the 9th FDA orphan drug qualification, the highest in China's Biopharmaceutical Enterprises

On January 5, 2021, AXA announced that the US Food and Drug Administration (FDA) recently granted the company the qualification of the orphan drug apg-2575, an original Bcl-2 inhibitor, for the...

Update January 04, 2021

be careful! Official implementation of Chinese pharmacopoeia in 2020

In July this year, the State Food and Drug Administration issued a notice on the implementation of the Pharmacopoeia of the people's Republic of China 2020, which is now December 31, 2020, which...